Individuals at risk for neurodegenerative diseases (e.g., Alzheimer’s disease) and those with metabolic diseases (e.g., non-alcoholic steatohepatitis [NASH] or diabetes) may benefit more from CAT due to the potential beneficial roles of CAT in neuronal function and metabolism. The gene discussed is CAT; the disease is early-onset autosomal dominant Alzheimer disease.